1. Bampalis VG, Dwivedi S, Shai E, Brandl R, Varon D, Siess W. Effect of 5-HT2A receptor antagonists on human platelet activation in blood exposed to physiological stimuli and atherosclerotic plaque. J Thromb Haemost 2011;9:2112-5. Pubmed.
  2. Butoi E, Gan AM, Manduteanu I, Stan D, Calin M, Pirvulescu M, Koenen RR, Weber C, Simionescu M. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/ CX3CR1 axis augments expression of pro-atherogenic molecules. BBA Mol Cell Res 2011;1813:2026-35. Pubmed
  3. Daissormont IT, Christ A, Temmerman L, Sampedro Millares S, Seijkens T, Manca M, Rousch M, Poggi M, Boon L, van der Loos C, Daemen M, Lutgens E, Halvorsen B, Aukrust P, Janssen E, Biessen EA. Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity. Circ Res 2011;109:1387-95. Pubmed
  4. de Jager SC, Bermúdez B, Bot I, Koenen RR, Bot M, Kavelaars A, de Waard V, Heijnen CJ, Muriana FJ, Weber C, van Berkel TJ, Kuiper J, Lee SJ, Abia R, Biessen EA. Growth Differentiation Factor-15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. J Exp Med 2011;208:217-25. Pubmed
  5. Douma K, Megens RT, van Zandvoort MA. Optical molecular imaging of atherosclerosis using nanoparticles: shedding light on the darkness. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011;3:376-88. Pubmed
  6. Drechsler M, Döring Y, Megens RTA, Soehnlein O. Neutrophilic granulocytes – promiscuous accelerators of atherosclerosis.Thromb Haemost 2011;106:839-48. Pubmed
  7. Engel D, Bechers L, Wijnands E, Seijkens T, Lievens D, Drechsler M, Gerdes N, Soehnlein O, Daemen MJ, Lutgens E. Caveolin-1 deficiency decreases atherosclerosis by hampering leukocyte influx into the arterial wall and cell response. FASEB J 2011;25:3838-48. Pubmed
  8. Frithiof R, Soehnlein O, Eriksson S, Fenhammar J, Hjelmqvist H, Lindbom L, Rundgren M. The effects of isoflurane anesthesia and mechanical ventilation on renal function during endotoxemia. Acta Anaesthesiol Scand 2011;55:401-10. Pubmed
  9. Gerdes N, Zhu L, Ersoy M, Hermansson A, Hiemdahl P, Hu H, Hansson GK, Li N. Platelets regulate CD4+ T-cell differentiation via multiple chemokines in humans. Thromb Haemost 2011;106:353-62. Pubmed
  10. Gerdes N, Zirlik A.Co-stimulatory molecules in and beyond co-stimulation - tipping the balance in atherosclerosis? Thromb Haemost 2011;106:804-13. Pubmed
  11. Goyal P, Behring A, Kumar A, Siess W. STK35L1 associates with nuclear actin and regulates cell cycle and migration of endothelial cells. PLoS One 2011;6:e16249. Pubmed
  12. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med 2011;17:293-307. Pubmed
  13. Heinrichs D, Knauel M, Offermanns C, Berres ML, Nellen A, Leng L, Schmitz P, Bucala R, Trautwein C, Weber C, Bernhagen J, Wasmuth HE. Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proc Natl Acad Sci USA 2011;108:17444-9. Pubmed
  14. Hristov M, Weber C. Differential role of monocyte subsets in atherosclerosis. Thromb Haemost 2011;106:757-62. Pubmed
  15. Khandoga AL, Pandey D, Welsch U, Brandl R, Siess W. GPR92/LPA5 lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques. Cardiovasc Res 2011;90:157-64. Pubmed
  16. Koenen RR, Weber C. Chemokines: established and novel targets in atherosclerosis. EMBO Mol Med 2011;3:713-25. Pubmed
  17. Kraemer S, Lue H, Zernecke A, Kapurniotu A, Andreetto E, Frank R, Lennartz B, Weber C, Bernhagen J. MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based two-site binding mechanism. FASEB J 2011;25:894-906. Pubmed
  18. Kramp B, Sarabi A, Koenen RR, Weber C. Heterophilic chemokine receptor interactions in chemokine signaling and biology. Exp Cell Res 2011;317:655-63. Pubmed
  19. Kuijpers MJ, Megens RT, Nikookhesal E, Feijge MA, De Mey JG, Oude Egbrink MG, van Giezen JJ, Heemskerk J. Role of newly formed platelets in thrombus formation in rat after binding P2Y12 antagonist ticagrelor. Thomb Haemost 2011;106:804-13. Pubmed
  20. Liehn E, Tuchscheerer N, Kanzler I, Drechsler M, Fraemohs L, Schuh A, Koenen RR, Zandler S, Soehnlein O, Hristov M, Grigorescu G, Urs A, Leabu M, Bucur I, Merx M, Zernecke A, Bernhagen J, Schober A, Weber C. Double-edged role of the CXCL12-CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol 2011;58:2415-23. Pubmed
  21. Lievens D, von Hundelshausen P. Platelets in atherosclerosis. Thromb Haemost 2011;106:827-38. Pubmed
  22. Lip GY, Weber C. Clinical and basic science articles from Thrombosis and Haemostasis. Thromb Haemost 2011;105:202-5. Pubmed
  23. Lutgens E, Binder CJ. Immunology of athersosclerosis. Thomb Haemost 2011;106:755-6. Pubmed
  24. Megens RT, Kemmerich K, Pyta J, Weber C, Soehnlein O. Intravital imaging of phagocyte recruitment. Thromb Haemost 2011;105:802-10. Pubmed
  25. Megens RT, Soehnlein O. Seeing is believing; an update on modalities to image inflammation in vivo. Thromb Haemost 2011;105:774-5. Pubmed
  26. Noels H, Bernhagen J, Weber C. MIF in atherosclerosis. In MIF: Most Interesting Factor revisited, edited by R Bucala, World Scientific Publishing 2012.
  27. Noels H, Weber C. Catching up with important players in atherosclerosis: type I interferons and neutrophils. Curr Opin Lipidol 2011;22:144-5. Pubmed
  28. Poggi M, Engel D, Christ A, Beckers L, Wijnands E, Boon L, Driessen A, Cleutjens J, Weber C, Gerdes N, Lutgens E. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice. Arterioscle Thromb Vasc Biol 2011;31:2251-60. Pubmed
  29. Rana OR, Saygili E, Gemein C, Zink MD, Buhr A, Saygili E, Mischke K, Nolte KW, Weis J, Weber C, Marx N, Schauerte P. Chronic electrical neuronal stimulation increases cardiac parasympathetic tone by eliciting neurotrophic effects. Circ Res 2011;108:1209-19. Pubmed
  30. Reitsma S, Oude Egbrink MG, Heijnen VV, Megens RTA, Engels W, Vink H, Slaaf DW, van Zandvoort MA. Endothelial glycocalyx thickness and platelet-vessel wall interactions during atherogenesis. Thromb Haemost 2011;106:939-46. Pubmed
  31. Sarabi A, Kramp B, Weber C, Koenen R, von Hundelshausen P. CXCL4L1 inhibits angiogenesis and induces undirected endothelial migration without affecting proliferation or monocyte recruitment. J Thromb Haemost 2011;9:209-19. Pubmed
  32. Saygili E, Schauerte P, Pekassa M, Saygili E, Rackauskas G, Schwinger RHG, Weis J, Weber C, Marx N, Rana OR. Sympathetic neurons express and secrete MMP-2 and MT1-MMP to control nerve sprouting via pro-NGF conversion. Cell Mol Neurobiol 2011;31:17-25. Pubmed
  33. Schober A, Hristov M, Forbrig R, Kofler S, Löhr B, Schumann U, Krötz F, Leibig M, König A, Kazcmerek I, Reichart B, Klauss V, Weber C, Sohn HY. Smooth muscle progenitor cells and CXCL12 predict the severity of cardiac allograft vasculopathy. Eur Heart J 2011;32:476-84. Pubmed
  34. Schober A, Weber C. Bone marrow-derived smooth muscle cells are breaking bad in atherogenesis. Arterioscler Thromb Vasc Biol 2011;31:1258-9. Pubmed
  35. Schober LJ, Khandoga AL, Dwivedi S, Penz SM, Maruyama T, Brandl R, Siess W. The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP(4) receptor activation and platelet function in whole blood. J Thromb Thrombolysis 2011;32:158-66. Pubmed
  36. Schuh A, Sasse A, Konschalla S, Kroh A, Merx MW, Weber C, Liehn EA. Repetitive transplantation of different cell types sequentially improves heart function after infarction. J Cell Mol Med 2012;16:1640-1647. Pubmed   
  37. Simons D, Grieb G, Hristov M, Pallua N, Weber C, Bernhagen J, Steffens G. Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment. J Cell Mol Med 2011;15:668-78. Pubmed
  38. Soehnlein O, Wantha S, Simsekyilmaz S, Doering Y, Megens RT, Mause SF, Drechsler M, Smeetz R, Einandy S, Schreiber F, Gries T, Vijayan S, van Zandvoort M, Agerberth B, Pham CT, Gallo RL, Hackeng TM, Liehn EA, Hristov M, Zernecke A, Klee D, Weber C. Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Sci Transl Med 2011;3:103ra98. Pubmed
  39. Vasina EM, Cauwenberghs S, Feijge MAH, Heemskerk JWM, Weber C, Koenen RR. Microparticles from apoptotic platelets promote resident monocyte subset differentiation. Cell Death Dis 2011;2:e210. Pubmed
  40. Vonende O, Ockenfels N, Gao X, Allolio B, Lang K, Mai K, Quack I, Saleh A, Degenhart C, Seufert J, Seiler L, Beuschlein F, Qunikler M, Podrabsky P, Biblingmaier M, Lorenz R, Reinke M, Rump LC. Adrenal venous sampling: evaluation of the German Conn`s registry. Hypertension 2011; 57:990-5. Pubmed
  41. Weber C, Lip GY. Commencing 2011 with Thrombosis and Haemostasis - and looking to the future. Thromb Haemost 2011;105:1-2. Link
  42. Weber C, Meiler S, Döring Y, Koch M, Drechsler M, Megens R, Rowinska Z, Bidzhekov K, Fecher C, Ribechini E, van Zandvoort M, Binder C, Jelinek Y, Hristov M, Boon L, Jung S, Korn T, Lutz MB, Förster I, Zenke M, Hieronymus T, Junt T, Zernecke A. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T-cell homeostasis in mice. J Clin Invest 2011;121:2898-910. Pubmed
  43. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011;17:1410-22. Pubmed
  44. Weber C, Soehnlein O. ApoE controls the interface linking lipids and inflammation in atherosclerosis. J Clin Invest 2011;121:3825-27. Pubmed
  45. Wildhagen KC, Lutgens E, Loubele ST, ten Cate H, Nicolaes GA. The structure-function relationship of activated protein C. Lessons from natural and engineered mutations. Thromb Haemost 2011;106:1034-45. Pubmed
  46. Ylä-Herttuala S, Bentzon JF, Daemen MJAP, Falk E, Garcia HM, Herrmann J, Hoefer I, Jukema JW, Krams R, Kwak B, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys PWJC, Waltenberger J, Weber C, Tokgözoglu L. Stabilisation of atherosclerotic plaques. Thromb Haemost 2011;106:1-19. Pubmed
  47. Ylä-Herttuala S, Bentzon JF, Daemen MJ, Falk E, Garcia HM, Herrmann J, Hoefer I, Jukema JW, Krams R, Kwak B, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys P, Watenberger J, Weber C, Tokgözoglu L. Stabilising atherosclerotic plaques: executive summary. Eur Heart J 2011. Pubmed
  48. Zhou Z, Subramanian P, Sevilmis G, Globke B, Soehnlein O, Karshovska E, Megens R, Heyll K, Reinholz M, van Zandvoort M, Weber C, Schober A. Lipoprotein-derived lysophosphatidic acid enhances atherosclerosis through the release of CXCL1 from endothelium. Cell Metab 2011;13:592-600. Pubmed


Prof. Dr. med. Christian Weber

Institute for Cardiovascular Prevention (IPEK)


Pettenkoferstraße 8a & 9

80336 München


Tel.: 089-4400-54351

Fax: 089-4400-54352

Mail: ipek.office@med.lmu.de